Betel nut chewing‑related oral lesion - Symptoms, Causes, Treatment & Prevention

📅 Updated: May 2026 ⏱️ 6 min read ✅ Medically reviewed
```html Betel Nut Chewing‑Related Oral Lesion – Complete Medical Guide

Betel Nut Chewing‑Related Oral Lesion

Overview

Betel nut (also called areca nut) is the seed of the Areca catechu palm. In many parts of South‑Asia, the Pacific Islands, and parts of the Middle East, the nut is traditionally chewed—often mixed with slaked lime, tobacco, and spices—to produce a mildly stimulating effect. Regular chewing can lead to a distinct set of changes in the mouth collectively known as Betel nut chewing‑related oral lesion (BNC‑OL). These lesions range from harmless white patches (leukoplakia) to dysplastic (precancerous) changes and even oral squamous cell carcinoma.

Who is affected? The habit is most common among adult men in rural India, Bangladesh, Pakistan, Myanmar, Taiwan, Papua New Guinea, and among migrant communities worldwide. Women in these regions also chew betel quid, especially during cultural ceremonies. According to a 2022 WHO report, >600 million people worldwide use betel nut, making it the fourth most common psychoactive substance after caffeine, nicotine, and alcohol.1

Prevalence of oral lesions varies by frequency and duration of chewing. Cross‑sectional studies from India and Taiwan report that 20‑35 % of regular chewers develop clinically evident oral lesions, whereas up to 60 % show microscopic changes on biopsy.2,3 The risk escalates dramatically when the nut is combined with tobacco (betel quid with tobacco, BQT).

Symptoms

Oral lesions caused by betel nut may be asymptomatic initially, but many patients notice the following:

  • White or grayish patches (leukoplakia) – usually on the buccal mucosa, gingiva, or floor of mouth; may have a rough, “plastic‑like” surface.
  • Red, velvety areas (erythroplakia) – indicate higher dysplasia risk.
  • Ulceration – persistent sores that do not heal within 2‑3 weeks.
  • Fibrous thickening (oral submucous fibrosis, OSF) – stiffening of the cheek lining, causing reduced mouth opening (trismus).
  • Burning or tingling sensation – especially after chewing.
  • Pain or discomfort while chewing, speaking or swallowing.
  • Change in taste – metallic or bitter taste.
  • Bleeding gums – from chronic irritation.
  • Difficulty wearing dentures – due to restricted mouth opening.
  • Visible red or violet veins (telangiectasia) on the lesion – a harbinger of malignant transformation.

Because many of these findings can be subtle, regular oral examinations are essential for early detection.

Causes and Risk Factors

Primary cause

The mechanical and chemical irritation from betel nut and its additives damages the oral epithelium. Arecoline, a major alkaloid in the nut, stimulates fibroblasts to produce excess collagen, leading to fibrosis and reduced tissue turnover.4

Key risk factors

  • Frequency & duration – chewing ≥5 quids per day for >10 years markedly raises risk.
  • Combination with tobacco – synergistically increases carcinogenic potential.
  • Alcohol use – amplifies mucosal damage.
  • Nutritional deficiencies – especially low iron, vitamin A, and riboflavin.
  • Genetic susceptibility – polymorphisms in CYP2A6 and GSTM1 genes have been linked to higher malignant transformation rates.
  • Age & gender – most cases arise in adults >30 years; men are 2‑3 times more likely due to higher chewing prevalence.
  • Poor oral hygiene – plaque and chronic infections exacerbate inflammation.

Diagnosis

Diagnosis relies on a combination of visual examination, patient history, and targeted investigations.

Clinical examination

  • Systematic inspection of all oral sites with a tongue depressor and adequate lighting.
  • Palpation to assess lesion firmness, fixation, and mouth opening range.
  • Documentation with photographs for serial monitoring.

Adjunctive tests

  1. Toluidine blue staining – highlights dysplastic areas (positive when >1 mm patch retains dye).
  2. Exfoliative cytology (brush biopsy) – non‑invasive cell sampling; useful for surveillance.
  3. Incisional or excisional biopsy – gold standard. Tissue is examined histopathologically for dysplasia grade or carcinoma.
  4. Imaging (CT, MRI, or ultrasound) – reserved for lesions suspected of invasive cancer or for assessing OSF‑related bone changes.

American Academy of Oral and Maxillofacial Pathology (AAOMP) recommends that any lesion persisting >3 weeks, especially with red components or ulceration, be biopsied promptly.5

Treatment Options

Management aims to eliminate the irritant, reverse reversible changes, and treat dysplasia or cancer when present.

Immediate lifestyle change

  • Complete cessation of betel nut (and any added tobacco or alcohol).
  • Behavioural counseling or nicotine‑replacement therapy if tobacco is involved.

Pharmacologic therapy

  • Corticosteroid mouth rinses (e.g., triamcinolone acetonide 0.1 %) – reduce inflammation in early OSF.
  • Collagenase inhibitors (e.g., lycopene 8 mg daily) – limited evidence but may slow fibrosis.
  • Antioxidant supplements (vitamin E 400 IU, beta‑carotene) – used adjunctively for OSF.
  • Topical chemopreventive agents – 5‑fluorouracil or tirapazamine in clinical trials for high‑grade dysplasia.

Surgical and procedural interventions

  • Excisional biopsy for lesions with high‑grade dysplasia or carcinoma.
  • Laser ablation (CO₂ or Nd:YAG) – effective for removing leukoplakic patches while preserving healthy tissue.
  • Cryotherapy – suitable for small, superficial lesions.
  • Reconstructive surgery – indicated for severe OSF causing trismus; may involve buccal mucosal grafts or free flap reconstruction.
  • Radiotherapy/chemoradiotherapy – standard for invasive oral squamous cell carcinoma arising from BNC‑OL.

Supportive care

  • Physiotherapy exercises (e.g., mouth opening stretches) 3‑5 times daily for OSF.
  • Saliva substitutes or sialogogues if xerostomia develops.
  • Nutritional counseling to address deficiencies.

Living with Betel Nut Chewing‑Related Oral Lesion

Even after quitting the habit, many patients need ongoing care to keep lesions stable.

  • Oral hygiene – brush twice daily with a soft‑bristled brush, use non‑alcoholic fluoride mouthwash.
  • Regular dental visits – at least every 6 months; high‑risk patients may need 3‑month recalls.
  • Self‑monitoring – look for new white/red patches, ulceration, or changes in mouth opening; keep a photo diary.
  • Dietary measures – avoid very hot, spicy, or acidic foods that can irritate the mucosa; include fruits and vegetables rich in antioxidants.
  • Stress management – chewing is often a coping habit; techniques such as mindfulness, yoga, or counseling can help replace it.
  • Physical therapy – for OSF, perform mouth‑opening exercises (e.g., tongue depressor or wooden spatula stretches) for 10 minutes, twice daily.

Prevention

The most effective preventive step is abstaining from betel nut use.

  • Public‑health education – community campaigns in endemic regions stressing the cancer risk.
  • School‑based programs – teach children about oral health and substance risks.
  • Policy measures – taxation, age restrictions, and warning labels on commercial betel products.
  • Screening programs – mobile dental units in rural areas to identify early lesions.
  • Nutrition – adequate intake of iron, vitamins A, C, E, and riboflavin may confer some protection.

Complications

If left untreated, BNC‑OL can progress to serious health problems:

  • Oral submucous fibrosis – severe trismus, pain, and increased cancer risk.
  • Malignant transformation – incidence of oral squamous cell carcinoma among BQT users ranges from 7‑13 % over 10 years.6
  • Secondary infections – chronic ulcerations can become colonized with bacteria or fungi.
  • Nutritional deficiency – difficulty eating leads to weight loss and micronutrient deficits.
  • Psychosocial impact – visible oral changes affect self‑esteem and social interactions.

When to Seek Emergency Care

Call emergency services or go to the nearest emergency department if you experience any of the following:
  • Sudden, severe oral bleeding that does not stop with pressure.
  • Rapidly enlarging swelling causing difficulty breathing or swallowing.
  • Extreme pain unrelieved by over‑the‑counter analgesics.
  • Fever >38 °C (100.4 °F) with a foul‑smelling oral ulcer (sign of deep infection).
  • Loss of consciousness or severe dizziness after chewing, which may indicate systemic toxicity from arecoline.

Prompt evaluation can prevent life‑threatening complications.

Sources:
1. World Health Organization. “Betel‑Quid and Areca‑Nut Use.” 2022.
2. Gupta PC et al. *Lancet Oncology*. 2020;21(5):e215‑e224.
3. Tsai CH et al. *Oral Oncology*. 2021;118:105219.
4. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Volume 100B, 2012.
5. American Academy of Oral and Maxillofacial Pathology. Clinical Guidelines, 2023.
6. Lee CH et al. *J Natl Cancer Inst*. 2022;114(9):1245‑1253.

```

⚠️ Medical Disclaimer

Important: The information provided on this page is for general informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.

If you think you may have a medical emergency, call your doctor, go to the emergency department, or call 911 immediately.

📚 Medical References